X0202 SCHEDULE 13G 0002148767 XXXXXXXX LIVE Class A ordinary shares 07/27/2026 0001809616 Universe Pharmaceuticals INC G9442G138 265 Jingjiu Avenue Jinggangshan Economic and Technological Jiangxi F4 343100 Rule 13d-1(c) Horizon Ridge Limited D8 0.00 499424.00 0.00 499424.00 499424.00 N 9.97 CO The amount in rows 6, 8 and 9 represents 499,424 Class A ordinary shares held by Horizon Ridge Limited, a company with limited liability formed in the British Virgin Islands. Horizon Ridge Limited is wholly owned and controlled by Shan Xie, an individual. Percentage of class is calculated based on 5,008,313 Class A ordinary shares outstanding as of July 27, 2026. Shan Xie F4 0.00 499424.00 0.00 499424.00 499424.00 N 9.97 IN The amount in rows 6, 8 and 9 represents 499,424 Class A ordinary shares held by Horizon Ridge Limited, a company with limited liability formed in the British Virgin Islands. Horizon Ridge Limited is wholly owned and controlled by Shan Xie, an individual. Percentage of class is calculated based on 5,008,313 Class A ordinary shares outstanding as of July 27, 2026. Universe Pharmaceuticals INC 265 Jingjiu Avenue, Jinggangshan Economic and Technological, Ji'an, Jiangxi, CHINA, 343100 Horizon Ridge Limited Shan Xie Horizon Ridge Limited: Vistra Corporate Services Centre, Wickhams Cay II, Road Town, Tortola, British Virgin Islands Shan Xie: Room 102, No. 25, Lane 1771, Hutai Road, Shanghai 200000, People's Republic of China Horizon Ridge Limited: British Virgin Islands Shan Xie: People's Republic of China Y Horizon Ridge Limited: 499,424.00 Shan Xie: 499,424.00 Horizon Ridge Limited: 9.97% Shan Xie: 9.97% See Row 5 of the cover page for each Reporting Person. See Row 6 of the cover page for each Reporting Person. See Row 7 of the cover page for each Reporting Person. See Row 8 of the cover page for each Reporting Person. Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Exhibit 99.1 - Joint Filing Agreement Horizon Ridge Limited /s/ Shan Xie 09/01/2026 Shan Xie /s/ Shan Xie 09/01/2026